M.Airoldi, A.Morton et al., World Calss Commisioning Isle of Wight NHS PCT:Priority Setting Event 29

(1)

Bibliografia

Abraham WT, Cardiac resynchronization therapyfor heart failure: biventricular pacing and beyond, Curr Opin Cardiol, 2002.

M.Airoldi, A.Morton et al., World Calss Commisioning Isle of Wight NHS PCT:Priority Setting Event 29

^th

September 2008, Internal Document, 2008

America Heart Association, Heart disease and stroke statistics – 2003 update, Dallas, TX:

American Heart Association, 2002.

Agenzia Regionale di Sanità della Toscana, La banca dati Macro delle malattie croniche in Toscana:Popolazioni con malattie croniche e indicatori di processo assistenziale, Dicembre 2009.

ARS Toscana, Malattie croniche negli anziani in Toscana: stime di popolazioni attuali e proiezioni future, Giugno 2008.

Asl di Bergamo, Le Residenze Sanitario Assistenziali per anziani in provincia di Bergamo, 2004.

Atkinson AB (2005). The Atkinson Review: Final report. Palgrave Macmillan

Azienda Ospedaliera “ospedale Niguarda Ca’ Granda” Milano, Linee Guida Insufficienza Cardiaca, Dicembre 2000

Azienda Usl 5 Pisa, Percorso assistenziale dello scompenso cardiaco, Giugno 2009.

Baltussen R, Floyd K, Dye C: Achieving the millennium goals for health: Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 2005, 333:1364-1370.

Baltussen R., Niessen L., Priority setting of health interventions: the need for multi-criteria decision analysis, BioMed Central , 2006.

U.J. Barr, S. Robinson, B. Marin-Link, L. Underhill, The Expanded Chronic Care Model, Hospital Quarterly 2003;Vol.7, No 1, 73-82.

A.D.Barretta, L’integrazione socio-sanitaria: ricerca scientifica ed esperienze operative a confronto, Il Mulino, 2009

H.J. Bethell, Exercise in cardiac rehabilitation, Br J Sports Med 1999 33: 79-86.

Gwyn Bevan, Mara Airoldi, Alec Morton and Mónica Oliveira, London School of Economics, Jennifer Smith, South Central Strategic Health Authority ( Feb. 2007), Estimating health and productivity gains in England from selected interventions: Executive summary, the Health Foundation, QQUIP ( Quest for Quality and Improved Performance).

Birch S., making the problem fit the solution: evidence based decision making and dolly economics,

In: Donaldson C., Mugford M., Vale L., eds. Evidence based Health Economics: From

Effectiveness to Efficiency in Systematic Review. London: BMJ Books, 2002.

(2)

T. Bodenheimer, E.H. Wagner, K. Grumbach, Improving primary care for patients with chronic illness, JAMA 2002; 288:1775-79.

Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289(6);730- 740.

Bristow M, Feldman A, Saxon LA. Cardiac resynchronization therapy reduces hospitalization and cardiac resynchronization therapy and implantable defibrillator reduces mortality in chronic heart failure: results of the Companion Trial. American College of Cardiology, 52nd Annual Scientific Session.

Butler J, Hanumanthu S, Chomsky D, Wilson JR., Frequency of low-risk hospital admissions for heart failure., Am J Cardiol 1998; 81: 41-4.

Cacciatore p. et al., Analisi dei ricoveri per insufficienza cardiaca Anni 2001-2003, Ministero della Salute 2007

S. Cantarelli et al., Il percorso del paziente : la gestione per processi in sanità, EGEA, c1999

Cleland et al., Non invasive home telemonitoring for patient with heart failure at high risk otùf recurrent admission and death, J of American College of Cardiology, 2005, 45(10), 1654-1664.

A.Curnis et al., Benefici e impatto a lungo termine sulla sopravvivenza della terapia di resincronizzazione cardiaca, Trattato italiano di elettrofisiologia ed elettrostimolazione cardiaca, vol. 2, 2009.

Devlin and Towse, "What research is required?", In Towse, Pritchard and Devlin (eds). Cost- effectiveness Thresholds. Economic and Ethical Issues. Kings Fund and Office of Health Economics., 2002

Dixon S., Booth A., Perret K., The application of evidence based priority setting in a District Health Authorit, J Public Health med, 1997.

G..Fattore et al., Management e qualità L’impatto economico della terapia di resincronizzazione in pazienti con scompenso cardiaco. Evidenze disponibili e valutazione del modello CRT-Eucomed per l’analisi del rapporto costo-efficacia, Ital Heart J Suppl 2005; 6 (12): 796-803.

Filmer D., Pritchett L., The impact of public spendine on health: does money matter?, Soc Sci Med 1999; 49:1309-23.

George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996).

Pharmacoeconomics 2001; 19 (11): 1103-9

Gobinet GA, Valli N, Filliatre H, Dubernet MF, Dedeystere O, Bordenave L. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin Chem Lab Med 2000; 38: 519- 23.

Gruppo di Lavoro Chronic Care Model Scompenso Cardiaco, L'ambulatorio orientato allo

scompenso cardiaco nell'ambito del Chronic Care Model, Toscana Medica, 2009.

(3)

Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130: 945-50.

K.Hauck et al., The Eeconomics of Priority Setting for Health Care: a Literature Reiew, HNP Discussion paper, 2004

Heidenreich et al., Cost-Effectiveness of Screening With B-Type Natriuretic Peptide to Identify Patients With Reduced Left Ventricular Ejection Fraction, Jl of the American College of Cardiology, 2004.

Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88:107-15.

Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA: Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat HIV/AIDS in developing

countries. BMJ 2005, 331:1431-7.

Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. Circulation 2001; 104: 2996-3007.

Kannel WB. Epidemiological aspects of heart failure. Cardiology Clinics 1989; 7: 1-9.

Keeney, R.L. And H.Raiffa (1976), Decision With Multiple Objectives: Preferences and Value Tradeoffs, New York, John Wiley.

Klein R., Warning signals from Oregon, British medical Journal, 1992.

Kosiborod M. et al., National trends in outcomes among elderly patient with chronic heart failure, AM J Med 2006 .

Laboratorio Management e Sanità, Il sistema di valutazione delle performance dei sistemi sanitari regionali: primi indicatori ministeriali, 2009

Laboratorio Management e Sanità, La valutazione della performance delle zone-distretto del sistema sanitario toscano, Anno 2008

Laboratorio Management e Sanità, Il Sistema di valutazione della performance della sanità toscana, REPORT 2007.

Leatherman S and Sutherland K (2005). The Quest for Quality in the NHS: A chartbook on quality of care in the UK. Radcliffe Publishing.

Leatherman S and Sutherland K (2003). The Quest for Quality in the NHS: A mid-term evaluation of the ten-year quality agenda. The Stationery Office.

Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-402

Linee guida per la valutazione multidimensionale dell’anziano fragile Giornale di Gerontologia

2001; 49 (suppl. 11)

(4)

C.Lucioni, Farmaco-economia significa risparmiare sul farmaco?, 63°Congresso Nazionale FIMMG , ottobre 2008.

M.Lucchetti et al., Lungodegenza, RSA ed ADI. Tre modalità assistenziali, nella regione Marche, a confronto, G GERONTOL 2004;52:140-152.

C.Lucioni, Come valutare i risultati di uno studio farmacoeconomico?, PharmacoEconomics - Italian Research Articles 6 (3): 121-130, 2004

Macchi C., Benvenuti F., Attività Fisica Adattata, Firenze, Libreria Mater, 2008

J. De Maeseneer et al., Primary health care as a strategy for achieving equitable care, a literature review commissioned by Health Systems Knowledge Network, WHO, March 2007.

S. Martin, P.C. Smith, S. Leatherman, Value for money in the English NHS: Summary of the evidence, QQUIP, Health Foundation, December 2006.

C.Mitton, C.Donaldson, Come stabilire le priorità in sanità, 2006.

Messori A et al., Controvalore economico del farmaco e beneficio clinico: stato dell’arte della metodologia e applicazione di un algoritmo farmacoeconomico, PharmacoEconomics – Italian Research Articles 2003; 5 (2): 53-67.

Ministero della Salute, Analisi dei ricoveri per insufficienza cardiaca in Italia – anni 2001-2003, Aprile 2007.

Monaldi Arch Chest Dis 2006; 66: 255-263

Mooney G.., Economics, medicine and Health care, 2nd ed. Brighton: Wheatsheaf, 1992.

Morimoto et al., Is B-type natriuretic peptide-guided heart failure management cost-effective?

International Journal of Cardiology 96 (2004) 177– 181

E.Mugnaini et al., SdS Empolese : la sintesi del profilo di salute, 2007.

MC Murray et al., Economics of chronic heart failure, European Journal of Heart Failure, 2001.

Murray C., Lopez A., The Global Burden of Disease, Boston: Harvard school of Public Health, 1996

Newman M., Popodopoulos I., Sigsworth S., Barries to evidence-based practice, Intensive Crit care Nurs, 1998.

New York Heart Association, The criteria committee of the New York Heart Association Nomenclature and criteria for diagnosis of the heart and blood vessels, Boston, 1964.

OECD Health Data 2006.

(5)

Oldridge, Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction, 1994, Medline

Oliveira et al., Estimating the impacts on health gains and costs from improving diagnsosis and treatment of Heart Failure in England, 2010.

Orn S., Dickstein K, How do heart failure patients die?, Eur heart J Suppl 2002.

Owen A., Life expectancy of elderly and very elderly patients with chronic heart failure, Am Heart J, 2006.

Patel et al., Home care as an option in worsening chronic heart failure—A pilot study to evaluate feasibility, quality adjusted life years and cost-effectiveness, European Journal of Heart Failure 10 (2008) 675–681.

Regione Toscana ,Giunta Regionale – Direzione Generale Diritto alla Salute e Politiche di Solidarietà, Area di Coordinamento Sanità : Medicina Predittiva-Preventiva, Decreto n.4052, 13 Agosto 2009.

Regione Toscana, Piano Sanitario Regionale 2008-2010.

Regione Toscana, Piano Sanitario regionale 2008-2010, Deliberazione del Consiglio Regionale n.53 del 16 luglio 2008.

Remme WJ, Swedberg K, for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527- 60.

Rengo F, Leosco D, Iacovoni A, et al. Epidemiologia clinica e fattori di rischio per scompenso cardiaco nell’anziano. Ital Heart J 2004; 5 (Suppl 10): 9-16.

Rich MW. Heart Failure in the 21st century: a cardiogeriatric syndrome. J Gerontol 2001; 56:

M88M96.

Rich MW. Heart failure disease management: a critical review. J Card Fail 1999; 5: 64-75.

Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344-50

Rosen R., Applying research to health care policy and practice: medical and managerial views on effectiveness and the role of research, J Health Serv Res Policy, 2000.

Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community. Trends in incidence and survival in a 10-year period. Arch Intern Med 1999; 159: 29-34.

Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-9.

Shiell A., Gerard K., Donaldson C., Cost of illness studies: an aid to decision making?, Health

policy 1987; 8: 317-23.

(6)

P.C.Smith, Measuring Value for Money in healthcare: concepts and tools, QQUIP Publication, September 2009.

Solomon SD et al., Influence of nonfatal hospitalization for heart failure on subsequent mortality in patient with chronic heart failure, Circulation 2007

Stewart S. et al., Heart failure and the aging population: an increasing burden in the 21st century?, Heart, 2003.

Swedberg K. Et al., Guidelines for the diagnosis and treatment of chronic heart failure ; full text ( update 2005), Eur Heart J, 2005

.

Swedberg K et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678-84.

Tengs TO et al., Five-hundred live saving interventions and their cost-effectiveness, Risk Analysis, 1995; (15) 3 : 369-390.

Testa M. et al., Cardiotossicità da chemioterapici: fattori di rischio e prevenzione, Cuore e vasi, anno XXIX - n.3, Settembre 2007

The Health Foundation, Commisioning with community: exploring how the Isle of Wight used a value for money approach to set local priorities, January, 2010.

The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:

685-91.

Turner et al., Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care, Heart (2008)

Tyagi V, Singh SK, Sawhney A. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse. Pharmacoeconomics, 2003, 21(7):497- 499.

Weinstein, M. C. 1996. From cost-effectiveness ratios to resource allocation: Where to draw the line? In Valuing Health Care: Costs, Benefits and Effectiveness of Pharmaceuticals and other Medical Technologies., edited by F. A. Sloan. New York: Cambridge University Press.

Winslow CM., Solom DH., Chassin MR. Et al., The appropriateness of carotid endarterectomy, N.Engl J Med 1988; 318: 721-7.

Winslow CM, Kosecoff JB., Chassin M., kanouse DE, Brook RH, The appropriateness of performing coronay artey bypass surgery, JAMA 1988; 260:505-9.

The World Bank World Development Report 1993: investing in Health. New York Oxford

University Press; 1993.

(7)

World Health Organization, Innovative care for chronic conditions, Building blocks for action, 2002, Geneva.

Zanassi A., Scompenso cardiaco e comorbilità nel paziente anziano ospedalizzato. Modello operativo informatizzato su PDA per la Primary Care, Tesi di Laurea Specialistica in Medicina e Chirurgia, Università degli studi di Modena e reggio Emilia, 2006-2007.

M. Zoni Berisso et al., Terapia di resincronizzazione cardiaca in combinazione con la funzione di cardioversione-defibrillazione: considerazioni su una superiorità terapeutica ancora da dimostrare, G Ital Cardiol 2010; 11(4): 295-305.